Cargando…

Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014

INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common illicit drugs, they represent a serious public health challenge due to the spike in intoxications and fatalities that have been linked to their use. This study aims to provide epidemiological data on NP...

Descripción completa

Detalles Bibliográficos
Autores principales: Neicun, Jessica, Yang, Justin Christopher, Shih, Hueyjong, Nadella, Pranay, van Kessel, Robin, Negri, Attilio, Czabanowska, Kasia, Brayne, Carol, Roman-Urrestarazu, Andres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598490/
https://www.ncbi.nlm.nih.gov/pubmed/33125395
http://dx.doi.org/10.1371/journal.pone.0241056
_version_ 1783602625347846144
author Neicun, Jessica
Yang, Justin Christopher
Shih, Hueyjong
Nadella, Pranay
van Kessel, Robin
Negri, Attilio
Czabanowska, Kasia
Brayne, Carol
Roman-Urrestarazu, Andres
author_facet Neicun, Jessica
Yang, Justin Christopher
Shih, Hueyjong
Nadella, Pranay
van Kessel, Robin
Negri, Attilio
Czabanowska, Kasia
Brayne, Carol
Roman-Urrestarazu, Andres
author_sort Neicun, Jessica
collection PubMed
description INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common illicit drugs, they represent a serious public health challenge due to the spike in intoxications and fatalities that have been linked to their use. This study aims to provide epidemiological data on NPS use in the USA, determining lifetime prevalence of use and defining demographic, socioeconomic, drug use patterns and mental health correlates. METHODS: This study uses secondary data from the US National Survey on Drug Use and Health (NSDUH), which is a large cross-sectional population-based survey carried out annually in the USA. We analysed data from 2007–14 (N = 307,935) using bivariate descriptive analysis and binary logistic regression to calculate prevalence and determine factors underlying NPS consumption. Adjusted odds ratios (OR) with 95% CI’s were calculated for a set of selected independent variables. RESULTS AND DISCUSSION: Our analysis NSDUH from 2007–14 highlights an increase in NPS use among adults, especially among white young men aged 18 to 25. Although the level of education of NPS users was relatively higher as compared to non-users, NPS users seemed to have a less wealthy situation. However, socioeconomic vulnerability appeared to be less important than mental health issues as a correlate to NPS use. NPS users seem to have followed a pattern of polysubstance use throughout their life, which involves both traditional illicit drugs and classic synthetic drugs. As NPS use seemed to be more prevalent among people having mental health issues, the rise in their use may have a negative impact on population mental health outcomes. CONCLUSION: Further comparative research on trends in NPS use and potential public health responses would be instrumental for developing appropriate health interventions, including drug checking, education for users and training for healthcare professionals working both within emergency wards and in/outpatient addiction and mental health services.
format Online
Article
Text
id pubmed-7598490
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-75984902020-11-03 Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014 Neicun, Jessica Yang, Justin Christopher Shih, Hueyjong Nadella, Pranay van Kessel, Robin Negri, Attilio Czabanowska, Kasia Brayne, Carol Roman-Urrestarazu, Andres PLoS One Research Article INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common illicit drugs, they represent a serious public health challenge due to the spike in intoxications and fatalities that have been linked to their use. This study aims to provide epidemiological data on NPS use in the USA, determining lifetime prevalence of use and defining demographic, socioeconomic, drug use patterns and mental health correlates. METHODS: This study uses secondary data from the US National Survey on Drug Use and Health (NSDUH), which is a large cross-sectional population-based survey carried out annually in the USA. We analysed data from 2007–14 (N = 307,935) using bivariate descriptive analysis and binary logistic regression to calculate prevalence and determine factors underlying NPS consumption. Adjusted odds ratios (OR) with 95% CI’s were calculated for a set of selected independent variables. RESULTS AND DISCUSSION: Our analysis NSDUH from 2007–14 highlights an increase in NPS use among adults, especially among white young men aged 18 to 25. Although the level of education of NPS users was relatively higher as compared to non-users, NPS users seemed to have a less wealthy situation. However, socioeconomic vulnerability appeared to be less important than mental health issues as a correlate to NPS use. NPS users seem to have followed a pattern of polysubstance use throughout their life, which involves both traditional illicit drugs and classic synthetic drugs. As NPS use seemed to be more prevalent among people having mental health issues, the rise in their use may have a negative impact on population mental health outcomes. CONCLUSION: Further comparative research on trends in NPS use and potential public health responses would be instrumental for developing appropriate health interventions, including drug checking, education for users and training for healthcare professionals working both within emergency wards and in/outpatient addiction and mental health services. Public Library of Science 2020-10-30 /pmc/articles/PMC7598490/ /pubmed/33125395 http://dx.doi.org/10.1371/journal.pone.0241056 Text en © 2020 Neicun et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Neicun, Jessica
Yang, Justin Christopher
Shih, Hueyjong
Nadella, Pranay
van Kessel, Robin
Negri, Attilio
Czabanowska, Kasia
Brayne, Carol
Roman-Urrestarazu, Andres
Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014
title Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014
title_full Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014
title_fullStr Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014
title_full_unstemmed Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014
title_short Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014
title_sort lifetime prevalence of novel psychoactive substances use among adults in the usa: sociodemographic, mental health and illicit drug use correlates. evidence from a population-based survey 2007–2014
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598490/
https://www.ncbi.nlm.nih.gov/pubmed/33125395
http://dx.doi.org/10.1371/journal.pone.0241056
work_keys_str_mv AT neicunjessica lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014
AT yangjustinchristopher lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014
AT shihhueyjong lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014
AT nadellapranay lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014
AT vankesselrobin lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014
AT negriattilio lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014
AT czabanowskakasia lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014
AT braynecarol lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014
AT romanurrestarazuandres lifetimeprevalenceofnovelpsychoactivesubstancesuseamongadultsintheusasociodemographicmentalhealthandillicitdrugusecorrelatesevidencefromapopulationbasedsurvey20072014